Recent SEC filings disclose the company’s capital structure challenges, including amendments and waivers to credit facilities and non-payment of certain interest obligations leading to events of default with temporary waivers in place.

• Trinseo PLC’s ordinary shares were delisted from the NYSE effective March 30, 2026, and now trade over the counter under the symbol TSEOF [S1].
• The company engaged in discussions with financial stakeholders to review potential alternatives regarding its capital structure, including refinancing and amendments to debt agreements [S1].
• In March 2026, Trinseo elected not to make certain scheduled interest payments under credit facilities, resulting in events of default; however, limited waivers temporarily waive enforcement rights of lenders [S1].
• Amendments and limited waivers were entered into with lenders under the super-priority revolving credit facility, senior credit agreement, refinance credit agreement, and accounts receivable securitization facility [S1].

Trinseo benefits from a leadership team with extensive experience in the chemical and manufacturing sectors, which supports strategic initiatives and operational management. The company’s access to multiple credit facilities and willingness to engage with financial stakeholders to amend and waive terms demonstrates proactive financial management. The board’s composition with diverse expertise in finance, operations, and industry knowledge provides governance strength. The company’s liquidity ratios, while moderate, indicate some capacity to meet short-term obligations as of the latest fiscal year-end.

The company reported a substantial net loss of $545.6 million for fiscal year 2025 and has experienced events of default due to non-payment of certain interest obligations, indicating financial distress. The delisting from the NYSE and transition to OTC trading may reduce liquidity and investor visibility. The current ratio of 1.21 and cash ratio of 0.21 suggest limited cash reserves relative to liabilities. The company’s ongoing need to negotiate amendments and waivers with lenders highlights risks related to capital structure and debt servicing. These factors may constrain operational flexibility and increase financial risk.

Trinseo’s moat is derived from its established position in the chemical industry, supported by a board and executive team with deep industry and operational expertise. The company’s access to multiple credit facilities and ongoing engagement with financial stakeholders to manage its capital structure reflect its operational scale and complexity. However, recent financial losses and liquidity challenges indicate vulnerabilities that may affect its competitive positioning. The company’s ability to navigate capital structure adjustments and maintain operational continuity is critical to sustaining its market presence.

• Financial Distress and Capital Structure Risk: The company has experienced events of default due to non-payment of interest on certain credit facilities, requiring amendments and waivers with lenders. This indicates financial distress and risks related to debt servicing and refinancing.
• Liquidity Constraints: Liquidity ratios as of December 31, 2025, show a current ratio of 1.21 and a cash ratio of 0.21, reflecting limited cash and short-term investment buffers against current liabilities.
• Market Listing and Trading Risks: The delisting from the NYSE and transition to OTC trading may reduce share liquidity, investor access, and market visibility, potentially impacting capital raising and shareholder value.
• Operational and Market Risks: The company operates in the chemical industry, which is subject to raw material cost volatility, regulatory compliance, and global economic conditions that may impact operations and financial performance.

• Trinseo PLC is a public limited company incorporated in Ireland with principal executive offices in Wayne, Pennsylvania.
• The company’s ordinary shares were delisted from the NYSE effective March 30, 2026, and now trade over the counter under the symbol TSEOF.
• As of December 31, 2025, Trinseo reported cash and cash equivalents of $146.7 million and current assets of $864.7 million against current liabilities of $714.7 million, resulting in a current ratio of 1.21 and a cash ratio of 0.21.
• For the fiscal year ended December 31, 2025, Trinseo reported a net loss of $545.6 million and basic and diluted earnings per share of -$15.24.
• The company’s revenue figure available is $1.2366 billion for the quarter ended June 30, 2018, from earlier filings.
• Trinseo has engaged in discussions with financial stakeholders regarding its capital structure, including refinancing and amendments to debt agreements.
• The company elected not to make certain scheduled interest payments under some credit facilities in March 2026, resulting in events of default but with limited waivers in place temporarily waiving enforcement rights.
• Amendments and limited waivers have been entered into with lenders under various credit facilities including a super-priority revolving credit facility, senior credit agreement, refinance credit agreement, and accounts receivable securitization facility.
• The company’s board of directors includes experienced executives with backgrounds in chemicals, manufacturing, finance, and operational leadership.
• The company’s governance disclosures include detailed biographies of directors and executive officers, highlighting expertise relevant to the chemical industry and corporate transformation.
• Liquidity ratios and financial disclosures are derived from the latest SEC filings and are provided for informational purposes only, not as financial advice.